Derma Sciences, Inc. Reports First Quarter Financial Results

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the three months ended March 31, 2014. Highlights of the first quarter of 2014 and recent weeks include:

•Advanced Wound Care (AWC) product sales increased 11.5% to $8.4 million, led by MEDIHONEY®, TCC-EZ® and XTRASORB®

Help employers find you! Check out all the jobs and post your resume.